Abdominal fat graft migration into bulbar subconjunctival space after midface fat transfer: a case report Authors: John D. Hong, Samir Nazarali, David Merriott, Daniel B. Azzam, Maria Del Valle Estopinal, Jeremiah P. Tao, Sanjay R. Kedhar Published: 2026 ABSTRACT A 69-year-old woman presented with a localized bulbar conjunctival lesion with associated inflammation. The lesion and inflammation were refractory to topical corticosteroid therapy. Her history was significant for cosmetic lower eyelid blepharoplasty with abdominal fat transfer to the midface. Surgical excision and histopathologic analysis revealed a foreign body-type granulomatous inflammatory reaction to lipid material, consistent with migrated corporal fat. This case outlines a rare complication of fat transfer to the periocular region. Introduction Cosmetic blepharoplasty is the most common facial plastic procedure and ranks among the top four plastic surgeries overall, with 115,261 cases reported in the U.S. in 2022.1 Both transconjunctival and transcutaneous approaches are widely used, with the transconjunctival technique reportedly employed by nearly all ASOPRS surgeons.2 Common adjunctive procedures for lower blepharoplasty include orbital fat excision, lateral canthal suspension, and fat repositioning.2 Fat grafting, in particular, has gained increasing popularity, offering comparable outcomes and complication rates to traditional fat repositioning.3 Reported complication rates include 11.2% for unsatisfactory aesthetic results or contour irregularities, 6.2% for hematoma, and 2.4% for revision surgery.4 Autologous fat is favored for its biocompatibility and durability, although its post-injection behavior can be unpredictable.5–7 We report a unique case of fat prolapse and migration to the bulbar subconjunctival space following cosmetic lower eyelid blepharoplasty with autologous fat transfer from the abdomen and flanks to the midface. All procedures conducted were in accordance with tenets of the Declaration of Helsinki and HIPAA regulations, pertaining to patient privacy and ethical standards in medical care and reporting. Case report A 69-year-old woman with a history of meibomian gland dysfunction and dry eye syndrome presented for evaluation of a persistent red left eye. Five months earlier, she had undergone bilateral transcutaneous lower cosmetic blepharoplasty with autologous fat transfer performed at an outside facility. Review of the operative notes indicates fat was harvested from the abdomen and flanks following infiltration with tumescent solution. A total of 16 cc of fat was injected to the face: 4 cc into each infraorbital area, 2 cc into each supraorbital sulcus, and 2 cc into each lateral orbital inferior rim and zygoma. The patient reported progressive conjunctival hyperemia associated with a stable, painless lesion involving the inferonasal bulbar conjunctiva of the left eye, first observed on postoperative day one. Topical fluorometholone acetate 0.1% had been prescribed by her referring ophthalmologist and continued for three months. She experienced mild improvement while on therapy but recurrent redness during steroid tapers. She denied any recent trauma, systemic illness, or significant ocular pain. Best-corrected visual acuity was 20/20 in both eyes. Slit lamp examination revealed 1+ conjunctival injection surrounding a well-circumscribed, elevated (>1 cm), translucent inferonasal bulbar subconjunctival lesion composed of clustered microlipid globules (Figure 1(A,B)). The patient initially deferred surgical excision for continued management on topical steroid therapy. Over the course of the next two months, the patient continued to have conjunctival inflammation on topical steroids. Due to persistent inflammation, foreign body sensation, and cosmetic appearance, the patient elected to proceed with surgical intervention. Under local anesthesia, an excisional biopsy of the lesion was done, resulting in a 7 × 6 mm conjunctival defect that was reconstructed by amniotic membrane transplant (AMT). Histopathologic examination revealed conjunctival stroma with collections of epithelioid histiocytes and foreign body-type multinucleated giant cells surrounding variable-sized empty lipid-type vacuoles which were highlighted with adipocyte differentiation-related protein (Adipophilin) immunohistochemical study (Figure 2(A–E)). Histochemical studies for detection of microorganisms (Gram stain, Grocott methenamine silver (GMS) and acid-fast bacilli (AFB)) failed to detect bacterial, fungal and mycobacterial agents. The combined clinical and histologic findings favored lipogranulomatous inflammation associated with autologous fat graft degradation. Postoperative recovery following AMT was uncomplicated (Figure 1(C)) with prednisolone acetate 1% tapered over several weeks. At postoperative week three, the patient was doing well with complete resolution of the lesion, improved cosmesis, and no recurrence or adverse sequelae. Discussion Although fat graft migration is a known risk of aesthetic procedures, migration of fat to the bulbar subconjunctival space following blepharoplasty with abdominal fat transfer to the midface is extremely rare.6,7 Fat graft migration typically manifests as contour irregularities, palpable subcutaneous nodules, or granulomatous inflammation.8,9 However, migration into the bulbar subconjunctival space may be misdiagnosed as a primary conjunctival lesion. Several operative factors in this case likely resulted in the observed complication. The surgical dissection and opening of the inferior orbital septum during transcutaneous lower blepharoplasty provided a direct anatomic conduit for fat graft material to enter the post-septal space. The high injection volumes, 4 cc to each infraorbital area and 2 cc to the comparatively tighter space of the lateral orbital inferior rim and zygoma, likely necessitated elevated injection pressures. Although the operative report did not provide specifics on injection cannula size, depth, or technique, the high mechanical pressure encountered likely resulted in difficult injection control, increasing the risk of inadvertent deep infiltration and mechanical displacement of fat graft material beyond intended planes. Facial fat transfers typically involve smaller injection cannulas around 20 G or higher, further contributing to high injection pressures. The operative report also did not specify harvesting cannula gauge or pore size. Facial fat transfers typically performed via Coleman technique involves harvesting cannulas around 2 mm in outer diameter with smaller side port pores to yield micro-fat lobules.10 Upon injection, the micro-fat lobules are likely more amenable to passage through disrupted planes into the post-septal region, with possible deposition into the subconjunctival potential space, consistent with the clustered micro-lipid globules observed on slit lamp. The appearance of the bulbar subconjunctival lesion on postoperative day one supports intraoperative seeding as the primary mechanism, as autologous fat grafts tend to stabilize and integrate within local tissue more rapidly than fillers that can still migrate long after injection.5,11 A less likely but possible alternative mechanism is superior fat graft migration if the superior orbital septum was incidentally compromised during injection to the supraorbital sulcus, though the inferonasal location of the lesion is more anatomically consistent with migration of fat graft injected to the infraorbital space. Histopathologic analysis confirmed foreign body-type granulomatous reaction to degraded lipid material (Figure 2(A–E)).12–15 However, intact adipocytes were not observed on the sections examined, possibly associated with necrosis of the graft, release of lipid droplets into the adjacent tissue, and secondary inflammatory response.12–15 Although autologous fat is biocompatible, the lipogranulomatous reaction could be due to necrosis from lack of perfusion within the subconjunctival space, and from traumatic harvesting especially if high suction through the smaller cannulas with narrow pores typically used in facial fat transfer.9,16,17 Necrotic release of free fatty acids and other inflammatory markers likely triggered a foreign body macrophage response to the fat graft material.13–16 Our patient also had pre-existing meibomian gland dysfunction and dry eye disease for a baseline inflamed ocular surface milieu, likely provoking a more readily robust granulomatous response. Furthermore, the local erythema at the site of the lesion with vascular recruitment extending from the medial canthus is likely secondary to poor perfusion of the subconjunctival fat mass and inciting an inflammatory response. On presentation, the fat mass was adherent to the conjunctiva and the months-long inflammatory response led to a pterygium-like lesion that required en bloc excision, leaving a large 7 × 6 mm defect that needed reconstruction by AMT. The limitations of this report include lack of technical details within operative report from outside clinic regarding harvesting and injection cannula specifications and technique regarding injection rate, depth, and planes. This case underscores the importance of including cosmetic surgical history in the evaluation of persistent conjunctival lesions and maintaining a broad differential that includes postoperative fat graft migration. The lesion’s clinical presentation and partial steroid responsiveness led to referral by the primary ophthalmologist to uveitis service, due to concern for persistent inflammation.18,19 However, the lesion’s well-circumscribed appearance and translucent microlipid collections raised suspicion for a foreign body reaction to migrated fat graft material following recent cosmetic blepharoplasty with fat transfer. Subconjunctival fat migration, while rare, should be suspected when clinical features include localized lipid-like deposits with minimal progression. Surgical excision and ocular surface reconstruction could be definitive in refractory or cosmetically concerning cases, particularly when inflammatory mimics have been ruled out.